Does Cardio Kill Gains? What HIIT and Lifting Studies Show
Does cardio kill muscle gains? A 16-week HIIT trial and meta-analyses show why cardio type, volume, timing, and training status shape the answer for lifters.
Cardio does not automatically steal muscle from your lifting program. In a 16-week randomized trial of 19 untrained young men, adding long-interval HIIT to resistance training did not reduce myofibrillar protein synthesis, satellite-cell responses, myonuclear accretion, or type II muscle-fiber growth versus resistance training alone. That finding does not erase the interference effect. It narrows it: the available evidence points more toward a problem of running modality, aerobic volume, and unresolved questions in trained athletes than a universal cardio-versus-gains conflict.
The familiar instruction to separate every cardio and lifting session came from a real concern. Early concurrent-training research used demanding combinations of endurance work and resistance exercise, often including high-volume running. Over time, that context became a gym rule: aerobic exercise and hypertrophy cannot coexist. Human trials and meta-analyses now support a less dramatic conclusion.
A direct test found no molecular penalty from adding HIIT
Conceiçào et al. (2026) randomized 19 untrained young men to 16 weeks of resistance training alone or the same resistance training combined with long-interval HIIT. The researchers did more than measure body composition. They used deuterium oxide to assess myofibrillar protein synthesis and serial muscle biopsies to examine satellite cells, myonuclei, myogenic regulatory factors, and individual fiber cross-sectional area.
Both groups increased myofibrillar protein synthesis over the intervention (time effect, P=0.0105), with no significant difference between groups. Type II satellite-cell content also increased over time (P=0.0021), again without a between-group difference. Myonuclear accretion occurred in type I fibers (P=0.0301) and type II fibers (P=0.0009) as time effects, with no significant attenuation in the concurrent group. Type II fiber cross-sectional area increased over 16 weeks (P=0.016), and the study found no group-level evidence that HIIT blunted that growth.
The concurrent group had a post-exercise increase in MYOD1 expression (P=0.0009). MYOD1 is involved in muscle-cell differentiation and repair, but this biomarker result does not prove that HIIT improves hypertrophy. It does show that the added aerobic work did not visibly silence the measured myogenic response in this protocol.
For recreational trainees, this is useful evidence: adding this form of HIIT did not dismantle the molecular machinery associated with hypertrophy. It is not a final answer for every program or athlete. Nineteen participants is a small sample, all were young untrained men, and the intervention tested one HIIT format. A null between-group result can miss a small effect, especially in people who gain muscle readily when they begin training.
Whole-muscle results are more reassuring than fiber-level results
The broader literature reaches two conclusions that look contradictory until you consider what each analysis measured. An updated 2022 meta-analysis by Schumann et al. found that concurrent aerobic and resistance training did not meaningfully compromise whole-muscle hypertrophy measured through outcomes such as lean mass and imaging-based muscle thickness, compared with resistance training alone.
That is the outcome most lifters care about: whether a muscle becomes larger in a measurable, visible sense. Still, whole-muscle measures are not interchangeable with biopsy results. A separate 2022 systematic review and meta-analysis by Lundberg et al. found a statistically significant but small attenuation in muscle-fiber cross-sectional area with concurrent training versus strength training alone.
Neither result cancels the other. A biopsy samples individual fibers; imaging and lean-mass measures assess a larger anatomical outcome. The small fiber-level signal may not produce a detectable difference in total muscle size under typical study conditions. Or the broader measurements may miss small structural differences. The studies do not settle that methodological question, so the honest reading is that whole-muscle hypertrophy appears broadly compatible with concurrent training while a small fiber-level cost remains plausible.
Running, volume, and protocol design likely matter more than timing
Modality is the clearest practical variable. Lundberg and colleagues found a more pronounced fiber-hypertrophy attenuation with running-based concurrent training than with cycling, particularly in type I fibers. Running creates substantial repetitive eccentric loading and can add fatigue without directly replacing a lifting session; that is a reasonable explanation, but the meta-analysis itself cannot prove the mechanism.
HIIT also appears less likely to interfere when aerobic volume stays low. In recreationally active men and women, Sterczala et al. (2024) found measurable muscle-fiber hypertrophy after high-intensity, low-volume concurrent resistance and interval training. That study supports a practical hypothesis: a smaller aerobic dose can coexist with muscle growth. It does not establish that every HIIT prescription is hypertrophy-neutral.
A 2023 meta-analysis by Monserda-Vilaró et al. directly compared continuous and intermittent concurrent endurance protocols for hypertrophy outcomes. Its relevance is straightforward: protocol structure may help explain why some concurrent programs show interference while others do not. Higher-volume continuous endurance work creates more opportunity for cumulative fatigue than brief interval work.
Session timing deserves less attention than many training plans give it. A meta-analysis by Markov et al. (2022) found that aerobic exercise can acutely reduce strength and power in trained men. If hard running leaves you unable to complete productive resistance work, the issue is practical before it becomes molecular.
But acute fatigue does not automatically become chronic hypertrophy loss. In an eight-week trial of 24 non-athletic women aged 45 to 65 with type 2 diabetes, Ghodrat et al. compared resistance training plus HIIT on the same days with the same training split across different days. The schedules produced different inflammatory and metabolic adaptations, but the study did not establish that either schedule was superior for hypertrophy. Its clinical population also limits what healthy lifters should infer.
The trained-athlete question remains open
Evidence in highly trained people is thin. A 2024 meta-analysis by Huiberts et al. found that concurrent training blunted lower-body strength in males but not females. It also found impaired VO2max gains in untrained participants, but not in trained or highly trained participants. Those results do not answer the hypertrophy question by training status, yet they show that responses to concurrent training can differ by population and outcome.
Lundberg et al. found no statistically significant hypertrophy-interference difference by training status in subgroup analyses, but trained cohorts were sparse. That is a limitation, not reassurance. A trained lifter has less room for adaptation than a novice, and a small training cost may matter more when progress comes slowly.
Mechanistic certainty is also overstated online. The usual explanation invokes AMPK suppressing mTORC1 after endurance work. The pathway is biologically plausible, but the evidence summarized here does not directly establish it as the main driver of interference at practical training volumes. In endurance athletes, Jones et al. (2021) found that aerobic-exercise intensity did not alter anabolic signaling after resistance exercise. Molecular signaling is not the same as long-term muscle growth, but it does not support a simple switch-off model.
What to do if muscle growth is the priority
- Choose cycling or low-volume HIIT when you can. Running produced the clearest fiber-level interference signal in pooled evidence, while cycling and interval-based programs appear less consistently problematic.
- Manage weekly aerobic volume. A large endurance dose can create fatigue that reduces lifting quality. Keep cardio proportional to your actual endurance goal.
- Protect the resistance session. If cardio and lifting occur close together, avoid letting the aerobic session reduce load, repetitions, or effort in the lifting work that drives your progress.
- Meet protein needs. A systematic review by Hartono et al. found that protein supplementation improved muscle protein synthesis and longer-term muscle-mass outcomes during concurrent resistance and endurance training. The review supports adequate protein as a useful modifiable factor, not as permission to out-eat unlimited training fatigue.
- Use your own results if you are well trained. Track body measurements, performance, recovery, and aerobic volume. Controlled evidence does not yet give trained athletes a precise universal rule.
For most untrained and recreationally trained people, cardio and lifting can coexist without an obvious hypertrophy penalty when the cardio is HIIT or cycling-based and the total endurance load remains sensible. High-volume running deserves more caution, and trained athletes still need better evidence than the current literature can offer.
Comments
No comments yet. Be the first!